- JP-listed companies
- JCR Pharmaceuticals Co.,Ltd.
- Balance sheet
JCR Pharmaceuticals Co.,Ltd.【JP:4552】Balance sheet
Market cap
¥91.7B
P/E ratio
29.2x
| 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Cash and cash equivalents | - | 1,137 | 1,949 | 5,509 | 4,895 | 7,836 | 10,973 | 26,260 | 30,733 | 13,278 | 18,756 | 13,196 |
| Marketable securities, current | - | 3,736 | 1,927 | 300 | 1,217 | 661 | 220 | - | 244 | - | - | - |
| Accounts receivable, net | - | 5,204 | 5,384 | 5,435 | 7,103 | 8,835 | 7,977 | 8,183 | 15,585 | - | - | - |
| Inventories | - | 1,523 | 1,582 | 1,757 | 1,759 | 2,281 | 880 | 1,367 | 2,121 | 1,098 | 2,111 | 2,571 |
| Total current assets | - | 17,191 | 18,366 | 20,315 | 23,327 | 27,368 | 28,342 | 48,545 | 62,188 | 47,802 | 57,581 | 51,056 |
| Property, plant and equipment, net | - | 11,612 | 11,445 | 11,388 | 10,853 | 11,061 | 14,875 | 17,172 | 26,782 | 32,681 | 30,040 | 37,410 |
| Marketable securities, non-current | - | 3,891 | 4,248 | 3,588 | 3,194 | 2,941 | 2,408 | 2,572 | 2,230 | 8,867 | 9,120 | 9,629 |
| Total non-current assets | - | 16,895 | 16,981 | 16,070 | 15,070 | 15,147 | 19,433 | 25,238 | 34,946 | 47,135 | 44,644 | 53,798 |
| Total assets | - | 34,086 | 35,347 | 36,385 | 38,398 | 42,516 | 47,775 | 73,784 | 97,134 | 94,937 | 102,226 | 104,855 |
| Accounts payable | - | 534 | 783 | 700 | 585 | 586 | 679 | 2,932 | 1,324 | - | - | - |
| Short-term debt | - | 1,950 | 1,760 | 1,494 | 2,893 | 3,630 | 4,880 | 12,850 | 15,150 | 16,800 | 8,950 | 23,005 |
| Long-term debt, current | - | 740 | 550 | 234 | 413 | 850 | 1,100 | 750 | 3,050 | 1,700 | 750 | 3,050 |
| Total current liabilities | - | 5,135 | 6,067 | 4,707 | 7,105 | 8,684 | 10,434 | 29,028 | 42,054 | 35,762 | 30,135 | 43,988 |
| Long-term debt, non-current | - | 717 | 647 | 2,713 | 2,500 | 1,850 | 3,800 | 4,750 | 2,450 | 5,500 | 14,350 | 12,050 |
| Total non-current liabilities | - | 2,686 | 2,217 | 4,092 | 3,764 | 2,957 | 4,761 | 6,199 | 3,990 | 6,761 | 15,615 | 13,431 |
| Total liabilities | - | 7,821 | 8,284 | 8,799 | 10,870 | 11,642 | 15,195 | 35,227 | 46,045 | 42,523 | 45,750 | 57,420 |
| Common stock and paid-in capital | - | 20,011 | 20,023 | 20,025 | 20,008 | 19,983 | 19,952 | 20,002 | 20,055 | 19,445 | 19,445 | 19,453 |
| Retained earnings | - | 5,780 | 6,930 | 8,149 | 10,469 | 13,350 | 15,039 | 20,904 | 33,241 | 34,273 | 37,278 | 31,191 |
| Stockholders' equity | 24,581 | 26,265 | 27,063 | 27,586 | 27,528 | 30,874 | 32,579 | 38,557 | 51,089 | 52,413 | 56,475 | 47,435 |